Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients

Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients

Currently, amrubicin is permitted for relapsed small-cell lung carcinoma (SCLC) only in Japan. The efficacy and adverse effects of amrubicin as reported by previous studies varied greatly. The inclusion criterion was a prospective study that was able to provide data for efficacy and safety by the AM...

Full description

Bibliographic Details
Main Authors:	Horita, Nobuyuki, Yamamoto, Masaki, Sato, Takashi, Tsukahara, Toshinori, Nagakura, Hideyuki, Tashiro, Ken, Shibata, Yuji, Watanabe, Hiroki, Nagai, Kenjiro, Nakashima, Kentaro, Ushio, Ryota, Ikeda, Misako, Kobayashi, Nobuaki, Shinkai, Masaharu, Kudo, Makoto, Kaneko, Takeshi
Format:	Online
Language:	English
Published:	Nature Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707435/

Similar Items

Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients
by: Horita, Nobuyuki, et al.
Published: (2015)

Sensitivity and specificity of Cobas TaqMan MTB real-time polymerase chain reaction for culture-proven Mycobacterium tuberculosis: meta-analysis of 26999 specimens from 17 Studies
by: Horita, Nobuyuki, et al.
Published: (2015)

Diagnostic test accuracy of loop-mediated isothermal amplification assay for Mycobacterium tuberculosis: systematic review and meta-analysis
by: Nagai, Kenjiro, et al.
Published: (2016)

Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis
by: Shibata, Yuji, et al.
Published: (2016)

Age, Dehydration, Respiratory Failure, Orientation Disturbance, and Blood Pressure Score Predicts In-hospital Mortality in HIV-negative Non-multidrug-resistant Smear-positive Pulmonary Tuberculosis in Japan
by: Nagai, Kenjiro, et al.
Published: (2016)

The BMW 803 A Aero Engine
Published: (1993)

Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited‐disease small cell lung cancer
by: Sekine, Ikuo, et al.
Published: (2016)

Effective Monotherapy with Amrubicin for a Refractory Extrapulmonary Small-Cell Carcinoma of the Liver
by: Isobe, Taichi, et al.
Published: (2009)

Review of the Management of Relapsed Small-Cell Lung Cancer with Amrubicin Hydrochloride
by: Kimura, Tatsuo, et al.
Published: (2011)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding, Qian, et al.
Published: (2013)

Amrubicin Monotherapy for Patients with Platinum-Refractory Gastroenteropancreatic Neuroendocrine Carcinoma
by: Ando, Takayuki, et al.
Published: (2015)

Pneumothorax triggered by the combination of gefitinib and amrubicin and treated with endobronchial silicone spigots
by: Imamura, Fumio, et al.
Published: (2015)

Incremental low doses of amrubicin for the treatment of bone marrow metastasis in small cell lung cancer
by: Asai, Nobuhiro, et al.
Published: (2013)

Regulatory role of heme oxygenase-1 in silica-induced lung injury
by: Kentaro Nakashima, et al.
Published: (2018-08-01)

Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan
by: Horita, Nobuyuki, et al.
Published: (2015)

Genetic model selection for a case–control study and a meta-analysis
by: Horita, Nobuyuki, et al.
Published: (2015)

C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin
by: Nagata, Misato, et al.
Published: (2013)

A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families
by: von Wachenfeldt, Anna, et al.
Published: (2007)

Antiproliferative and cell apoptosis-inducing activities of compounds from Buddleja davidii in Mgc-803 cells
by: Wu, Jian, et al.
Published: (2012)

Reduction of apoptosis by proanthocyanidin-induced autophagy in the human gastric cancer cell line MGC-803
by: NIE, CHAO, et al.
Published: (2016)

Delayed school progression and mental health problems in adolescence: a population-based study in 10,803 adolescents
by: Tempelaar, Wanda M, et al.
Published: (2014)

CITN-06: a Phase I/expansion trial of alt-803, an IL-15 superagonist, in patients with advanced melanoma
by: Margolin, Kim, et al.
Published: (2014)

Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: a propensity score matching study
by: Horita, Nobuyuki, et al.
Published: (2013)

Evidence suggesting that oral corticosteroids increase mortality in stable chronic obstructive pulmonary disease
by: Horita, Nobuyuki, et al.
Published: (2014)

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies
by: Horita, Nobuyuki, et al.
Published: (2014)

Diagnostic test accuracy of D-dimer for acute aortic syndrome: systematic review and meta-analysis of 22 studies with 5000 subjects
by: Watanabe, Hiroki, et al.
Published: (2016)

Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer
by: Sun, Yan, et al.
Published: (2016)

Biomass and morphology of fine roots of sugi (Cryptomeria japonica) after 3 years of nitrogen fertilization
by: Noguchi, Kyotaro, et al.
Published: (2013)

The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8+ T cells into innate-like effector cells with antitumor activity
by: Wong, Hing C, et al.
Published: (2013)

CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer
by: Wang, Liang, et al.
Published: (2016)

Cooperative therapeutic anti-tumor effect of IL-15 agonist ALT-803 and co-targeting soluble NKG2D ligand sMIC
by: Basher, Fahmin, et al.
Published: (2015)

Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo
by: WEI, WEIYUAN, et al.
Published: (2015)

Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
by: Xu, Wenxin, et al.
Published: (2015)

Enhanced efficacy of IL-15-based ALT-803 superagonist complex in combination with immune checkpoint inhibitors in hematologic and metastatic mouse tumor models
by: Xu, Wenxin, et al.
Published: (2014)

The IL-15 superagonist ALT-803 enhances anti-CD20 antibody-directed NK cell ADCC and in vivo clearance of B cell lymphomas
by: Rosario, Maximillian, et al.
Published: (2014)

Combinatorial therapy with an IL-15 superagonist (ALT-803) and anti-PD-L1 mAb augment T cell mediated anti-tumor immunity in mice
by: Johnson, Christopher B, et al.
Published: (2014)

L type Ca2+ channel blockers prevent oxaliplatin-induced cold hyperalgesia and TRPM8 overexpression in rats
by: Kawashiri, Takehiro, et al.
Published: (2012)

Clinico-pathological analysis referring hemeoxygenase-1 in acute fibrinous and organizing pneumonia patients
by: Hara, Yu, et al.
Published: (2015)

Involvement of Receptor-like Protein Tyrosine Phosphatase ζ/RPTPβ and Its Ligand Pleiotrophin/Heparin-binding Growth-associated Molecule (HB-GAM) in Neuronal Migration
by: Maeda, Nobuaki, et al.
Published: (1998)

Reliability and Validity of Quantifying Absolute Muscle Hardness Using Ultrasound Elastography
by: Chino, Kentaro, et al.
Published: (2012)